Socius Pharma Limited
Registered name: SOCIUS PHARMA LIMITED
Part of Cbpe Capital LLP groupSocius Pharma Limited made £706m revenue and £3.7m profit in the year to 30 Apr 2024. read from filing text
Socius Pharma Limited’s revenue grew 53% to £706m in the year to 30 Apr 2024, with £3.7m profit and 433 employees. The company is classified under “activities of financial services holding companies” and is based in Swadlincote; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Swadlincote, East Midlands
- Age
- 11 yrs · since 2014
- Type
- Private Limited Company
Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Apr 2022 | 30 Apr 2023 | 30 Apr 2024 |
|---|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | |||
| Revenue (turnover) | £306m | £460m | £706m |
| Cost of sales | £293m | £441m | £673m |
| Gross profit | £13.2m | £19.3m | £32.6m |
| Operating profit | £2.2m | £3.6m | £6.2m |
| Profit before tax | £2.1m | £3.4m | £5.6m |
| Profit after tax | £1.6m | £2.5m | £3.7m |
| Profit (best available) | £1.6m | £2.5m | £3.7m |
| Employees (average) | 203 | 263 | 433 |
| Ratios | |||
| Profit margin | 0.5% | 0.5% | 0.5% |
| Gross margin | 4.3% | 4.2% | 4.6% |
| Revenue per employee | £1.5m | £1.8m | £1.6m |
| Profit per employee | £8k | £9.6k | £8.5k |
| Growth (year on year) | |||
| Revenue growth | — | — | ▲53.3% |
| Profit growth | — | — | ▲46.3% |
| Headcount growth | — | — | ▲64.6% |
| Balance sheet — indirect signals, not revenue | |||
| Net assets | £0 | £0 | £0 |
| Source | Accounts · bulk data Dec 2023 | Accounts · bulk data Dec 2023 | FullAccounts · bulk data Jan 2025 |
How the business works
- Profit margin
- 0.5%
- Profit ÷ revenue.
- Gross margin
- 4.6%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £1.6m
- Revenue ÷ average employees.
- Profit per employee
- £8.5k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now £0
- Cash at bank
- —
- Now —
- Headcount
- ▲65%
- Now 433
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Cbpe Capital LLPultimate parent50–75%
- Apollo 2024 Topco Limited75–100%
- Apollo 2024 Midco Limited75–100%
- Apollo 2024 Holdco Limited75–100%
- Apollo 2024 Bidco Limited75–100%
- Socius Pharma Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Subsidiaries (1)
- Global Orphan Associates LimitedRev. £0 · Profit £0
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from FullAccounts for the year to 30 Apr 2024 (profit £3.7m), from the Companies House accounts bulk data published Jan 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.